MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array.

Albiges, Laurence; Guegan, Justine; Le Formal, Audrey; Verkarre, Virginie; Rioux-Leclercq, Nathalie; Sibony, Mathilde; Bernhard, Jean-Christophe; Camparo, Philippe; Merabet, Zahira; Molinie, Vincent; Allory, Yves; Orear, Cedric; Couvé, Sophie; Gad, Sophie; Patard, Jean-Jacques; Escudier, Bernard.
Clin Cancer Res; 20(13): 3411-21, 2014 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-24658158